Capillary ketone level and future ketoacidosis risk in patients with type 1 diabetes using sodium-glucose cotransporter inhibitors
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We aimed to determine if routine capillary blood ketone testing on well days predicts future diabetic ketoacidosis (DKA) in type 1 diabetes (T1D) using sodium–glucose cotransporter inhibitors (SGLTi). RESEARCH DESIGN AND METHODS: We examined previously collected data from empagliflozin-assigned participants in a T1D trial that included weekly fasted ketone levels. Over 6–12 months, ketone levels were subdivided into 28-day periods, and the outcome was subsequent adjudicated DKA or severe ketosis. RESULTS: Among 1,194 participants, 325 had 49 DKA and 568 severe ketosis events. On-treatment maximum ketone levels were higher in the 28 days before an outcome compared with levels in those without an outcome, with area under receiver operating characteristic curve of 0.76 (95% CI 0.71–0.82). Maximum ketone level ≥0.8 mmol/L had sensitivity of 66.0%, specificity of 79.6%, and diagnostic odds ratio of 7.6. CONCLUSIONS: Routine surveillance of capillary ketone levels in T1D using SGLTi may represent a DKA mitigation strategy and implies a potential threshold for continuous ketone monitoring.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In clinical trials of SGLT2 inhibitors in adults with type 1 diabetes, fasting β-hydroxybutyrate of 0.8 mmol/L or higher increased the risk of DKA in the next month by 3.2fold (166).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [166]
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Cherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
Self-citationCherney, D. Z., Perkins, B. A., Soleymanlou, N., Har, R., Fagan, N., Johansen, O., Woerle, H.-J., von Eynatten, M., & Broedl, U. C. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-28 · Cited by 470
Self-citationDanne, T., Garg, S., Peters, A. L., Buse, J. B., Mathieu, C., Pettus, J. H., Alexander, C. M., Battelino, T., Ampudia-Blasco, F. J., Bode, B. W., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2316 · Cited by 379
Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
Rosenstock, J., Marquard, J., Laffel, L. M., Neubacher, D., Kaspers, S., Cherney, D. Z., Zinman, B., Skyler, J. S., George, J., Soleymanlou, N., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1749 · Cited by 363
Self-citationSGLT2 inhibitors as adjunctive therapy for type 1 diabetes: Balancing benefits and risks
Taylor, S. I., Blau, J. E., Rother, K. I., & Beitelshees, A. L. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30154-8 · Cited by 124
Peters, A. L., Henry, R. R., Thakkar, P., Tong, C., & Alba, M. (2016) · Diabetes Care · doi:10.2337/dc15-1995 · Cited by 106
Feasibility of Continuous Ketone Monitoring in Subcutaneous Tissue Using a Ketone Sensor
Alva, S., Castorino, K., Cho, H., & Ou, J. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211008185 · Cited by 93
Cited by
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
Verhoeff, N. J., Cheema, W., Mojdehi, S., Gad, H., Mumford, D., WANISS, M. R., Orszag, A., Jain, A., Bapat, P., BUDHRAM, D. R., et al. (2025) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2025.11.002 · Cited by 4
Self-citationReggiani, J. P. C., Rêgo, B. F., Santos, R. F. D. S., Moreira, I. O., Nascimento, J. O. B., Guimarães, C. D. B. C. C., de Matos, L. A., de Oliveira, D. L. L., Setubal, T. L., Oliveira, M. D. O. D., et al. (2025) · Seven Editora eBooks · doi:10.56238/edimpacto2025.028-009
A Patient–Clinician Codesigned Infographic for Diabetic Ketoacidosis Education in Type 1 Diabetes
WANISS, M. R., Cheema, W., Cheema, T., Mumford, D., Verhoeff, N., Gad, H., PARIKH, E., Budhram, D., Bapat, P., Zhang, Y., et al. (2026) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2026.05.002
Self-citationGlycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real‐World National Study
Audrain, E., Lassen, P. B., Bellanné‐Chantelot, C., Vantyghem, M., Dupuis, H., Vidal-Trécan, T., Chevalier, N., Dubois‐Laforgue, D., Lamothe, S., Vatier, C., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71169
Zhang, Y., Budhram, D., Bapat, P., Dhaliwal, S., PARIKH, E., Gad, H., Orszag, A., Cheema, W., BAKHSH, A., Verhoeff, N. J., et al. (2026) · Diabetes Care · doi:10.2337/dc26-1110
Self-citation
Metadata
- Authors
- Bapat, P., Dhaliwal, S., Song, C., Zhang, Y., Scarr, D., Bakhsh, A., Budhram, D., Verhoeff, N. J., Weisman, A., Fralick, M., Ivers, N. M., Cherney, D. Z. I., Tomlinson, G., Mumford, D., Lovblom, L. E., & Perkins, B. A.
- Affiliations
- Mount Sinai Hospital (CA)
- Women's College Hospital (CA)
- University Health Network (CA)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2025-04-23
- Volume
- 48
- Issue
- 6
- Pages
- 1016-1021
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4409781835
- Cited by
- 4
- References
- 20
- Citations by year
- 2026: 2 · 2025: 2
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Diabetes Canada (OG-3-21-5572-BP)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, diabetic ketoacidosis, sodium-glucose cotransporter inhibitors, empagliflozin, ketone monitoring
- MeSH terms
- Sodium-Glucose Transporter 2 Inhibitors, Adult, Benzhydryl Compounds, Capillaries, Diabetes Mellitus, Type 1, Female, Glucosides, Humans, Hypoglycemic Agents, Ketones, Male, Diabetic Ketoacidosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.